Mental disorders associated with multiple sclerosis;Psychische störungen als begleiterkrankungen der multiplen sklerose

Deutsche Medizinische Wochenschrift

Volumn 131, Issue 4, 2006, Pages 154-158

  Wilkening, Anja ^a   Haltenhof, H ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; CHOLINESTERASE INHIBITOR; CITALOPRAM; CORTISONE; DONEPEZIL; METHYLPREDNISOLONE; MIRTAZAPINE; MITOXANTRONE; NEUROLEPTIC AGENT; OLANZAPINE; PREDNISOLONE;

ADULT; AGITATION; ARTICLE; AUDITORY HALLUCINATION; BEHAVIOR THERAPY; BORDERLINE STATE; CASE REPORT; COGNITIVE DEFECT; DEPRESSION; DIFFERENTIAL DIAGNOSIS; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; FEMALE; HUMAN; IMPULSE CONTROL DISORDER; INFLAMMATION; INJURY; MALE; MENTAL DISEASE; MULTIPLE SCLEROSIS; OBSESSIVE COMPULSIVE DISORDER; PSYCHOTHERAPY; QUALITY OF LIFE; SELF CONCEPT; SUICIDAL BEHAVIOR; SUICIDAL IDEATION;

ADULT; ATTITUDE TO HEALTH; CORTISONE; DEPRESSION; FEMALE; HALLUCINATIONS; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; MULTIPLE SCLEROSIS; OBSESSIVE-COMPULSIVE DISORDER; QUALITY OF LIFE; SUICIDE, ATTEMPTED;

EID: 32044474857     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-924938     Document Type: Article

References (30)

1. Barak Y, Achiron A. Effect of interferon-beta-1b on cognitive function in multiple sclerosis. Eur Neurol 2002; 47: 11-14
2. Becker H. Psychotische Erscheinungsbilder als Erstmanifestation einer Multiplen Sklerose. Psychiat Prax 1997; 24: 69-73
3. Benedict RH, Carone DA, Bakshi R. Correlating brain atrophy with cognitive dysfunction, mood disturbances, and personality disorder in mutliple sclerosis. J Neuroimag 2004; 14: 36S-45S(Suppl
4. Bobholz JA, Rao SM. Cognitive dysfunction in multiple sclerosis: a review of recent developments. Curr Opin Neurol 2003; 16: 283-288
5. Boerner RJ, Kapfhammer HP. Psychopathological changes and cognitive impairment in encephalomyelitis disseminata. Eur Arch Psychiatry Clin Neurosci 1999; 249: 96-102
6. Caine ED, Schwid SR. Multiple sclerosis, depression, and the risk of suicide. Neurology 2002; 59: 662-663
7. Chan A, Rieckmann P, Gold R. Die immunmodulatorische Frühbehandlung der Multiplen Sklerose. Nervenheilkunde 2001; 20: 237-243
8. Driessen M, Beblo T, Reddemann L et al. 1st die Borderline- Persönlichkeitsstörung eine komplexe posttraumatische Störung? Zum Stand der Forschung. Nervenarzt 2002; 73: 820-829
9. Engel C, Greim B, Zettl UK. Kognitive Defizite bei Multipler Sklerose. Nervenarzt 2005; 76: 943-953
10. Faustmann PM, Wolf HC, Kastrup O, Ganz RE. Bipolare affektive Psychose und Multiple Sklerose. Nervenheilkunde 2000; 19: 570-574
11. Feinstein A, du Boulay G, Ron MA. Psychotic illness in multiple sclerosis. A clinical and magnetic resonance imaging study. Br J Psychiatry 1992; 161: 680-685
12. Feinstein A. An examination of suicidal intent in patients with multiple sclerosis. Neurology 2002; 59: 674-678
13. Felgenhauer K. Psychiatric disorders in the encephalitic form of multiple sclerosis. J Neurol 1990; 237: 11-18
14. Freyne A, Shelley RK. Obsessive compulsive disorder and multiple sclerosis: a case report implicating serotonergic dysfunction. Irish J Psychol Med 1994; 11: 26-27
15. Frühwald S, Löffler-Stastka H, Eher R, Saletu B, Baumhackl U. Zusammenhänge zwischen Depression, Angst und Lebensqualität bei Multipler Sklerose. Wien Klin Wochenschr 2001; 113: 333-338
16. George MS, Kellner CH, Fossey MD. Obsessive-compulsive symptoms in a patient with multiple sclerosis. J Nerv Ment Dis 1989; 177: 304-305
17. Haase CG, Tinnefeid M, Lienemann M, Ganz RE, Faustmann P. Depression and cognitive impairment in disability-free early multiple sclerosis. Behav Neurol 2003; 14: 39-45
18. Janardhan V, Bakshi R. Quality of life in patients with multiple sclerosis: the impact of fatigue and depression. J Neurol Sci 2002; 205: 51-58
19. Kordon A, Hohagen F. Neurobiologische Aspekte zur Ätiologie und Pathophysiologie der Zwangsstörung. Psychother Psychosom med Psychol 2000; 50: 428-434
20. Krupp LB, Christodoulou C, Melville P, Schert WF, MacAllister WS, Elkins LE. Donepezil improved memory in multiple sclerosis in a randomized clinical trial. Neurology 2004; 63: 1579-1585
21. McIntosh-Michaelis SA, Roberts MH, Wilkinson SM et al. The prevalence of cognitive impairment in a community survey of multiple sclerosis. Br J Clin Psychol 1991; 30: 333-348
22. Miguel EC, Stein MC, Rauch SL, O'Sullivan RL, Stern TA, Jenike MA. Obsessive-compulsive disorder in patients with multiple sclerosis. J Neuropsych Clin Neurosci 1995; 7: 507-510
23. Multiple Sklerose Konsensusgruppe (MSTKG). Leitlinien zur Multiplen Sklerose der Deutschen Gesellschaft für Neurologie, www.dgn.org.
24. Patten SB, Metz LM. Depression in multiple sclerosis. Psychother Psychosom 1997; 66: 286-292
25. Rao SM, Leo GJ, Bernardin L, Unverzagt F. Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology 1991; 41: 685-691
26. Sadovnick AD, Remick RA, Allen J et al. Depression and multiple sclerosis. Neurology 1996; 46: 628-632
27. Schwid SR, Covington M, Segal BM, Goodmann AD. Fatigue in multiple sclerosis: current understanding and future directions. J Rehabil Res Dev 2002; 39: 211-224
28. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mörk S, Bö L. Axonal transection in the lesion of multiple sclerosis. N Engl J Med 1998; 338: 278-285
29. Walther EU, Dietrich E, Hohlfeld R. Therapie der multiplen Sklerose mit Interferon-beta-1b. Nervenarzt 1996; 67: 452-456
30. Zorzon M, de Masi R, Nasuelli D et al. Depression and anxiety in multiple sclerosis. A clinical and MRI study in 95 subjects. J Neurol 2001; 248: 416-421